CLINICAL TRIALS PROFILE FOR PROPULSID
✉ Email this page to a colleague
All Clinical Trials for PROPULSID
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00372970 ↗ | Placebo Controlled Trial of Botulinum Toxin for Gastroparesis | Completed | American College of Gastroenterology | N/A | 2003-07-01 | It is hypothesized that in some patients with gastroparesis increased pyloric tone may be a contributing feature. Botox relaxes the pylorus so that food can empty the stomach more rapidly. Lesser quality studies have shown that this treatment works in about 40% of patients, and relieves symptoms for up to 3 months. This study compares this treatment to placebo (saline) injection. After a 1 month period patients may elect to receive open label botox who have not received relief from their first injection. Patients symptoms and gastric emptying are followed for 1 year. |
NCT00372970 ↗ | Placebo Controlled Trial of Botulinum Toxin for Gastroparesis | Completed | Temple University | N/A | 2003-07-01 | It is hypothesized that in some patients with gastroparesis increased pyloric tone may be a contributing feature. Botox relaxes the pylorus so that food can empty the stomach more rapidly. Lesser quality studies have shown that this treatment works in about 40% of patients, and relieves symptoms for up to 3 months. This study compares this treatment to placebo (saline) injection. After a 1 month period patients may elect to receive open label botox who have not received relief from their first injection. Patients symptoms and gastric emptying are followed for 1 year. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PROPULSID
Condition Name
Clinical Trial Locations for PROPULSID
Trials by Country
Clinical Trial Progress for PROPULSID
Clinical Trial Phase
Clinical Trial Sponsors for PROPULSID
Sponsor Name